References
- Li Y. Establishment of experimental models for Alzheimer's disease research. Int J Neurosci 2013;123:823–31.
- Wang X, Yu S, Hu JP, Streptozotocin-induced diabetes increases amyloid plaque deposition in AD transgenic mice through modulating AGEs/RAGE/NF-κB pathway. Int J Neurosci 2014; Epub ahead of print.
- Zarros A, Liapi C, Galanopoulou P, Effects of adult-onset streptozotocin-induced diabetes on the rat brain antioxidant status and the activities of acetylcholinesterase, (Na+,K+)- and Mg2+-ATPase: modulation by L-cysteine. Metab Brain Dis 2009;24:337–48.
- Salkovic-Petrisic M, Knezovic A, Hoyer S, What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's research. J Neural Transm 2013;120: 233–52.
- Park SA. A common pathogenic mechanism linking type-2 diabetes and Alzheimer's disease: evidence from animal models. J Clin Neurol 2011;7:10–8.
- Ejaz Ahmed M, Khan MM, Javed H, Amelioration of cognitive impairment and neurodegeneration by catechin hydrate in rat model of streptozotocin-induced experimental dementia of Alzheimer's type. Neurochem Int 2013;62:492–501.
- Correia SC, Santos RX, Santos MS, Mitochondrial abnormalities in a streptozotocin-induced rat model of sporadic Alzheimer's disease. Curr Alzheimer Res 2013;10:406–19.
- Mehla J, Pahuja M, Gupta YK. Streptozotocin-induced sporadic Alzheimer's disease: selection of appropriate dose. J Alzheimers Dis 2013;33:17–21.
- Park SJ, Kim YH, Lee Y, Selection of appropriate reference genes for RT-qPCR analysis in a streptozotocin-induced Alzheimer's disease model of cynomolgus monkeys (Macaca fascicularis). PLoS One 2013;8:e56034.
- Chen Y, Liang Z, Tian Z, Intracerebroventricular streptozotocin exacerbates Alzheimer-like changes of 3xTg-AD mice. Mol Neurobiol 2014;49:547–62.
- Chen Y, Tian Z, Liang Z, Brain gene expression of a sporadic (icv-STZ mouse) and a familial mouse model (3xTg-AD mouse) of Alzheimer's disease. PLoS One 2012;7: e51432.
- Gao C, Liu Y, Jiang Y, Geniposide ameliorates learning memory deficits, reduces Tau phosphorylation, and decreases apoptosis via GSK3β pathway in streptozotocin-induced Alzheimer rat model. Brain Pathol 2014; Epub ahead of print.
- Sodhi RK, Singh N. All-trans retinoic acid rescues memory deficits and neuropathological changes in mouse model of streptozotocin-induced dementia of Alzheimer's type. Prog Neuropsychopharmacol Biol Psychiatry 2013;40:38–46.
- Lee Y, Kim YH, Park SJ, Insulin/IGF signaling-related gene expression in the brain of a sporadic Alzheimer's disease monkey model induced by intracerebroventricular injection of streptozotocin. J Alzheimers Dis 2014;38:251–67.
- Heo JH, Lee SR, Lee ST, Spatial distribution of glucose hypometabolism induced by intracerebroventricular streptozotocin in monkeys. J Alzheimers Dis 2011;25:517–23.
- Grieb P, Kryczka T, Fiedorowicz M, Expansion of the Golgi apparatus in rat cerebral cortex following intracerebroventricular injections of streptozotocin. Acta Neurobiol Exp (Wars) 2004;64:481–9.
- Braidy N, Muñoz P, Palacios AG, Recent rodent models for Alzheimer's disease: clinical implications and basic research. J Neural Transm 2012;119:173–95.